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BackgroundaaCerebral venous thrombosis (CVT) is a distinct disorder with highly variable 
symptoms and courses. Malignancy is known to be one of the predisposing factors of CVT. 
Case ReportaaWe present the case of a 69-year-old man with sudden behavioral changes. 
Brain MRI, magnetic resonance venography, and positive D-dimer assay confirmed the pre-
sence of CVT. The work-up for detecting the cause of the CVT revealed occult prostate cancer. 
ConclusionsaaOccult malignancy including prostate cancer should be strongly suspected in 
older patients with idiopathic CVT. 
  J Clin Neurol  2009;5:195-197
 





Cerebral venous thrombosis (CVT) is an infrequently occur-
ring type of cerebrovascular disease with a wide spectrum of 
clinical presentations and is notoriously difficult to diagnose. 
Several disorders can cause or predispose patients to CVT, 
including all medical, surgical, and gyneco-obstetric causes 
of deep vein thrombosis in the legs, genetic and acquired pro-
thrombotic disorders, cancer, hematological diseases, vasculi-
tis and inflammatory systemic disorders, pregnancy and puer-
perium, infections, and several local causes such as brain tu-
mors, arteriovenous malformations, head trauma, CNS infec-
tions, and ear, sinus, mouth, face, or neck infections.
1 Diag-
nostic and therapeutic procedures such as surgery, lumbar 
puncture, jugular catheter, and some drugs (particularly oral 
contraceptives, hormonal replacement therapy, steroids, and 
cancer treatments) can also cause or predispose people to 
CVT. However, the relative likelihood of these causes varies 
with the age and country of origin of the patient.
2  
In the absence of an obvious provoking risk factor, the 
presence of an underlying malignancy is often considered 
because some types of cancer appear to be able to initiate or 
trigger a thrombotic diathesis through various mechanisms. 
However, CVT as the presenting sign of occult prostate can-
cer has not been reported in the English literature. We des-
cribe the case of a 69-year-old man with a CVT. The work-





A 69-year-old man was admitted to hospital because of sud-
den behavioral changes. Three days prior to admission, he ex-
perienced difficulty in using a television remote control and 
writing a letter, he was clumsy with spoons and chopsticks, 
and he had forgotten the personal identification number of 
his bank account. He had no history of diabetes, hyperten-
sion, smoking, alcoholism, or cardiac disorders. A neurologi-
cal examination revealed ideational apraxia, finger agnosia, 
alexia, and right-to-left disorientation. Minimal dysarthria, 
right central type facial nerve palsy, and pronator drifting of 
the right arm were also noted. Sensory and cerebellar func-
tions were normal. Brain MRI revealed a hemorrhagic in-
farction in the left parietal lobe (Fig. 1A). Magnetic reson-
ance (MR) angiography showed no arterial abnormality, but 
MR venography revealed occlusion of the left transverse si-
nus (Fig. 1B). The results of the following laboratory tests 
were normal or negative: electrocardiogram, complete blood 
cell count, sedimentation rate, blood sugar, lipid battery, ho-
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time, partial thromboplastin time, lupus anticoagulant, an-
tithrombin III, factor VIII, antiphospholipid antibody, anti-
cardiolipin antibody, antinuclear antibody, antineutrophil cy-
toplasmic antibodies, protein C, protein S, C3, C4, CH-50, C-
reactive protein, and antistreptolysin O. However, the plasma 
levels of D-dimer were elevated (1,700 ng/mL).  
To search for the predisposing factors of CVT, we perform-
ed gastrofiberscopy, colonoscopy, chest CT, abdomen CT, and 
serological tumor marker studies, but no abnormalities were 
revealed. The level of prostate specific antigen was markedly 
elevated (11.8 ng/mL), so an aspiration needle biopsy sam-
ple of the prostate gland was taken. Analysis of the sample 




Malignancy is associated with a high risk of developing th-
romboembolic disease and is related mainly to the genera-
tion of an intrinsic hypercoagulable state as a result of tumor 
induction of platelet aggregation and expression of various 
procoagulant factors including tissue factor and thrombin. 
Circulating carcinoma mucins can induce platelet-rich mi-
crothrombi without thrombin, a process that is inhibited by 
heparins but not by warfarin. Activation of the coagulation 
system appears to be intricately linked to processes that con-
trol tumor growth and angiogenesis.
3 Expression of tissue 
factor in tumors leads to an angiogenic phenotype via the up-
regulation of vascular endothelial growth factor and down-
regulation of the angiogenesis inhibitor thrombospondin.
4 
We found no similar reports in the literature of CVT as the 
presenting sign of occult prostate cancer.
5 Most series of th-
romboembolism associated with occult cancers are about deep 
venous thrombosis of the legs or pulmonary embolism.
3,5 It 
is not clear what percentage of patients with unprovoked 
venous thromboembolism harbor an asymptomatic occult 
malignancy. Several studies have found that approximately 
8-12% of patients who presented with venous thromboem-
bolism were diagnosed as having cancer after a relatively 
simple medical examination based upon symptoms and rou-
tine laboratory testing.
6-8 Over 5% of men diagnosed with 
prostate cancer have an antecedent thromboembolic event 
without any traditional risk factors for venous thromboem-
bolism.
5 However, there are no case reports involving pros-
tate cancer patients with antecedent CVT in those series.   
Because of the wide variety and nonspecificity of the pre-
senting symptoms of CVT, it would be of great practical im-
portance to develop an easy-to-perform test for the emer-
gency room that would reliably rule out CVT. The presence 
of D-dimer, which comprises fragments of cross-linked fi-
brin digested by plasmin, indicates the activation of both the 
blood coagulation system and the fibrinolytic system. Indeed, 
D-dimer concentrations are increased in most patients with 
recent CVT so that a negative D-dimer assay result may 
make the diagnosis of CVT highly unlikely. The sensitivity, 
specificity, and positive and negative predictive values of 
conventional D-dimer levels of >500 ng/mL for the diagnosis 
of CVT are all 100%.
9  
Our patient has some features that differ from typical pa-
tients with CVT. CVT is a distinct cerebrovascular disorder 
that, unlike arterial stroke, most often affects young adults 
and children. The majority (about 75%) of the adult patients 
are female, but this is not the case for children or the elderly. 
CVT in elderly people has received little attention. In one 
study, 8.2% of 624 consecutive adult patients with sympto-
matic CVT were aged 65 years or older.
10 Our case also has 
several implications for practice. CVT must be included in 
the differential diagnosis of elderly patients presenting with 
decreased alertness, delirium, or mental changes, because 
CVT does not usually present in the elderly as headache or 
isolated intracranial hypertension.   
The coincidence of these two entities cannot be comple-
tely ruled out in older patients. However, occult malignancy 
including prostate cancer should be strongly suspected in 
older patients with idiopathic CVT.   
Fig. 1. Brain MRI and magnetic reson-
ance (MR) venography (AP view). A: He-
morrhagic infarction was noted in the
left parietal lobe on T2-weighed imag-
ing. B: MR venography showed occlu-
sion of the left transverse sinus. 
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